These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 33255253)

  • 1. Alkaloids: Therapeutic Potential against Human Coronaviruses.
    Fielding BC; da Silva Maia Bezerra Filho C; Ismail NSM; Sousa DP
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
    Santopolo S; Riccio A; Santoro MG
    Biochem Biophys Res Commun; 2021 Jan; 538():80-87. PubMed ID: 33303190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marine Brominated Tyrosine Alkaloids as Promising Inhibitors of SARS-CoV-2.
    El-Demerdash A; Hassan A; Abd El-Aziz TM; Stockand JD; Arafa RK
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
    Prashantha CN; Gouthami K; Lavanya L; Bhavanam S; Jakhar A; Shakthiraju RG; Suraj V; Sahana KV; Sujana HS; Guruprasad NM; Ramachandra R
    J Mol Graph Model; 2021 Jan; 102():107769. PubMed ID: 33152616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.
    Shagufta ; Ahmad I
    Eur J Med Chem; 2021 Mar; 213():113157. PubMed ID: 33486200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(7):571-596. PubMed ID: 33463470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein.
    Pei P; Qin H; Chen J; Wang F; He C; He S; Hong B; Liu K; Qiao R; Fan H; Tong Y; Chen L; Luo SZ
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34180984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
    Idrees M; Khan S; Memon NH; Zhang Z
    Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies.
    Diniz LRL; Perez-Castillo Y; Elshabrawy HA; Filho CDSMB; de Sousa DP
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2.
    Das M; Kumar M; Jha A; Madhukiran DR; Bharti K; Mondal S; Mishra B
    Curr Drug Targets; 2021; 22(11):1232-1254. PubMed ID: 33371846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology.
    Zhuo LS; Wang MS; Yang JF; Xu HC; Huang W; Shang LQ; Yang GF
    Top Curr Chem (Cham); 2021 Apr; 379(3):23. PubMed ID: 33886017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review.
    Gonzalez BL; de Oliveira NC; Ritter MR; Tonin FS; Melo EB; Sanches ACC; Fernandez-Llimos F; Petruco MV; de Mello JCP; Chierrito D; de Medeiros Araújo DC
    Phytother Res; 2022 Jul; 36(7):2686-2709. PubMed ID: 35355337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valinomycin as a potential antiviral agent against coronaviruses: A review.
    Zhang D; Ma Z; Chen H; Lu Y; Chen X
    Biomed J; 2020 Oct; 43(5):414-423. PubMed ID: 33012699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Romeo A; Iacovelli F; Falconi M
    Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development.
    Wang MY; Zhao R; Gao LJ; Gao XF; Wang DP; Cao JM
    Front Cell Infect Microbiol; 2020; 10():587269. PubMed ID: 33324574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild?
    Rawat P; Jemimah S; Ponnuswamy PK; Gromiha MM
    Proteins; 2021 Apr; 89(4):389-398. PubMed ID: 33210300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.